Comparison of mesenchymal stem cells from human placenta and bone marrow

Chinese Medical Journal

Volumn 117, Issue 6, 2004, Pages 882-887

  Zhang, Yi ^a   Li, Chang Dong ^b   Jiang, Xiao Xia ^a   Li, He Lian ^b   Tang, Pei Hsien ^a   Mao, Ning ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Bone marrow; Hematopoietic cytokines; Mesenchymal stem cells; Placenta

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD34 ANTIGEN; CD45 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; FLT3 LIGAND; HERMES ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; MESSENGER RNA;

ADIPOCYTE; ARTICLE; ASSAY; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; DENSITY GRADIENT; FLOW CYTOMETRY; FRACTIONATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MESENCHYME; MULTIPOTENT STEM CELL; OSTEOBLAST; OSTEOCYTE; PLACENTA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DIFFERENTIATION;

BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; MESENCHYMAL STEM CELLS; PLACENTA; PREGNANCY;

EID: 3242662605     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
2. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9: 641-650.
3. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992;49: 225-233.
4. Haynesworth, SL, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1α. J Cell Physiol 1996;166:585-592.
5. Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57-66.
6. Majumdar MK, Thiede MA, Haynesworth SE et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages Hematother. Stem Cell Res 2000;9:841-848.
7. Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316.
8. Minguell JJ, Conget P, Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res 2000;33:881-887.
9. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28:875-884.
10. Ralf H. Isolation of Primary and Immortalized CD34-Hematopoietic and Mesenchymal Stem Cells from Various Sources. Stem Cells 2000;18:1-9.
11. Steinborn A, Gall CV, Hildenbrand R, et al. Identification of placental cytokine-producing cells in term and preterm labor. Obstet Gynecol 1998;91:329-35.
12. Gough NM, William RL, Hilton DJ et al. LIF: a molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells. Reprod Fertil Dev 1989;1:281-288.
13. Murray P, Edgar D. The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF). Differentiation 2001;86:227-234.
14. Kadereit S, Deeds LS, Haynesworth S, et al. Expansion of LTC-ICs and Maintenance of p21 and BCL-2 Expression in Cord Blood CD34+/CD38 - Early Progenitors Cultured over Human MSCs as a Feeder Layer. Stem Cells 2002;20:573-582.
15. Rao MS, Mattson MP. Stem cells and aging: expanding the possibilities. Mech Ageing Dev 2001;122:713-734.
16. Jaroscak J, Smith T, Haynesworth S. et al. Preliminary characterization of the surface staining of placental derived adherent cells: A potential new souece of stroma for umbilicol cord blood (UCB) expansion. Blood 2000;96:150b Abstract 4348.
17. Carow CE, Hangoc G, Broxmeyer HE, et al. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood 1993;81:942-949.
18. Bertolini F, Lazzari L, Lauri E, et al. Cord blood plasma-mediated ex vivo expansion of hematopoietic progenitor cells. Bone Marrow Transplant 1994;14:347-353.
19. Ruggieri L, Heimfeld S, Broxmeyer HE. Cytokine-dependent ex vivo expansion of early subsets of CD34 + cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Blood Cells 1994;20:436-454.
20. Whittle WL, Gibb WJ, Challis RJ. The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 2000;21:394-401.
21. Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999;265:134-139.
22. Barry F, Boynton R, Murphy M, et al. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 2001;289:519-524.